Cell Growth & Differentiation, Vol 9, Issue 11 887-896, Copyright © 1998 by American Association of Cancer Research

ARTICLES

Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1

SM de Toledo, EI Azzam, P Keng, S Laffrenier and JB Little
Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

Induced cell cycle delays were among the first described cellular responses to ionizing radiation (IR). To understand the sensitivity and the molecular events involved in the response to low doses of IR and to examine the role of p53 and its downstream effector p21Waf1, we measured changes in expression of genes postulated to be involved in the cellular response to IR. Expression levels were examined in normal human diploid fibroblasts irradiated and maintained in quiescent density-inhibited growth up to 24-48 h after exposure to X-ray doses as low as 0.1-0.3 Gy, which have negligible effects on cell survival. Among 31 genes analyzed, we observed down-regulation in response to IR of the mRNA levels of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51. A similar reduction in the expression levels of these genes occurred when irradiated cells were released from confluence and allowed to proliferate. This was not observed in cells in which p53 function was defective and up-regulation of p21Waf1 levels either did not occur (E6 transfected normal human fibroblasts and Li-Fraumeni fibroblasts) or was delayed (ataxia telangiectasia fibroblasts) after irradiation. Down-regulation was also absent in p21Waf1-null mouse embryo fibroblasts (MEFs) but occurred at a lower level in p53-null MEFs, due to slight increases in p21Waf1 levels by a p53-independent pathway. These findings indicate that the down-regulation of these cell cycle regulated genes in irradiated cells is p53-dependent and involves its effector p21Waf1. Although no down-regulation in the expression of genes involved in G2-M was observed in p53 or in p21Waf1-null MEFs, these cells showed a G2-M delay after irradiation, indicating that the expression levels of these genes does not regulate the G2-M delay.

This article has been cited by other articles:

				Y. Menda, L. L. Boles Ponto, K. J. Dornfeld, T. J. Tewson, G. L. Watkins, M. K. Schultz, J. J. Sunderland, M. M. Graham, and J. M. Buatti Kinetic Analysis of 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy J. Nucl. Med., July 1, 2009; 50(7): 1028 - 1035. [Abstract] [Full Text] [PDF]

				H. Shen, D. M. Moran, and C. G. Maki Transient Nutlin-3a Treatment Promotes Endoreduplication and the Generation of Therapy-Resistant Tetraploid Cells Cancer Res., October 15, 2008; 68(20): 8260 - 8268. [Abstract] [Full Text] [PDF]

				R. Leibowitz-Amit, G. Tsarfaty, Y. Abargil, G. M. Yerushalmi, J. Horev, and I. Tsarfaty Mimp, a Mitochondrial Carrier Homologue, Inhibits Met-HGF/SF-Induced Scattering and Tumorigenicity by Altering Met-HGF/SF Signaling Pathways. Cancer Res., September 1, 2006; 66(17): 8687 - 8697. [Abstract] [Full Text] [PDF]

				K. Lemke, V. Poindessous, A. Skladanowski, and A. K. Larsen The Antitumor Triazoloacridone C-1305 Is a Topoisomerase II Poison with Unusual Properties Mol. Pharmacol., October 1, 2004; 66(4): 1035 - 1042. [Abstract] [Full Text] [PDF]

				S. Polager and D. Ginsberg E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress J. Biol. Chem., January 10, 2003; 278(3): 1443 - 1449. [Abstract] [Full Text] [PDF]

				L. Fletcher, Y. Cheng, and R. J. Muschel Abolishment of the Tyr-15 Inhibitory Phosphorylation Site on cdc2 Reduces the Radiation-induced G2 Delay, Revealing a Potential Checkpoint in Early Mitosis Cancer Res., January 1, 2002; 62(1): 241 - 250. [Abstract] [Full Text] [PDF]

				P. M. Flatt, L. J. Tang, C. D. Scatena, S. T. Szak, and J. A. Pietenpol p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent Mol. Cell. Biol., June 15, 2000; 20(12): 4210 - 4223. [Abstract] [Full Text]

				H. Stopper, S. O. Mueller, and W. K. Lutz Supra-additive genotoxicity of a combination of {gamma}-irradiation and ethyl methanesulfonate in mouse lymphoma L5178Y cells Mutagenesis, May 1, 2000; 15(3): 235 - 238. [Abstract] [Full Text] [PDF]

				E. I. Azzam, S. M. de Toledo, A. J. Waker, and J. B. Little High and Low Fluences of {{alpha}}-Particles Induce a G1 Checkpoint in Human Diploid Fibroblasts Cancer Res., May 1, 2000; 60(10): 2623 - 2631. [Abstract] [Full Text]

				B.-D. Chang, K. Watanabe, E. V. Broude, J. Fang, J. C. Poole, T. V. Kalinichenko, and I. B. Roninson Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases PNAS, April 11, 2000; 97(8): 4291 - 4296. [Abstract] [Full Text] [PDF]

				C. Badie, J. E. Itzhaki, M. J. Sullivan, A. J. Carpenter, and A. C. G. Porter Repression of CDK1 and Other Genes with CDE and CHR Promoter Elements during DNA Damage-Induced G2/M Arrest in Human Cells Mol. Cell. Biol., April 1, 2000; 20(7): 2358 - 2366. [Abstract] [Full Text]

				R. Iyer and B. E. Lehnert Factors Underlying the Cell Growth-related Bystander Responses to {{alpha}} Particles Cancer Res., March 1, 2000; 60(5): 1290 - 1298. [Abstract] [Full Text]

				W. R. Taylor, S. E. DePrimo, A. Agarwal, M. L. Agarwal, A. H. Schönthal, K. S. Katula, and G. R. Stark Mechanisms of G2 Arrest in Response to Overexpression of p53 Mol. Biol. Cell, November 1, 1999; 10(11): 3607 - 3622. [Abstract] [Full Text]

				T. M. Passalaris, J. A. Benanti, L. Gewin, T. Kiyono, and D. A. Galloway The G2 Checkpoint Is Maintained by Redundant Pathways Mol. Cell. Biol., September 1, 1999; 19(9): 5872 - 5881. [Abstract] [Full Text] [PDF]

				C. Schmutte, G. Tombline, K. Rhiem, M. M. Sadoff, R. Schmutzler, A. von Deimling, and R. Fishel Characterization of the Human Rad51 Genomic Locus and Examination of Tumors with 15q14-15 Loss of Heterozygosity (LOH) Cancer Res., September 1, 1999; 59(18): 4564 - 4569. [Abstract] [Full Text] [PDF]